Showing posts with label 2013 Meeting Included Discussion Regarding Compounding Issues. Show all posts
Showing posts with label 2013 Meeting Included Discussion Regarding Compounding Issues. Show all posts

Thursday, July 18, 2013

Wisconsin Board of Pharmacy July 17, 2013 Meeting Included Discussion Regarding Compounding Issues

Contact: Dan Williams (608) 266-2112
Room 121A, 1400 E. Washington Avenue, Madison
JULY 17, 2013
Notice: The following agenda describes the issues that the Board plans to consider at the meeting. At the time of the
meeting, items may be removed from the agenda. Please consult the meeting minutes for a description of the actions
and deliberations of the Board.
FULL BOARD MEETING
9:00 A.M.
OPEN SESSION - CALL TO ORDER – ROLL CALL
A. Approval of Agenda (1-4)
B. Approval of Meeting Minutes of May 22, 2013 (5-12)
C. Administrative Updates – Discussion and Consideration
1) Ashley Horton – Division of Legal Services and Compliance – Monitoring Liaison Roles and
Delegated Authority (13-14)
2) Staff Updates
D. Presentation of Proposed Stipulations, Final Decisions and Orders
1) 12 PHM 078 – Karie L Tully R. Ph.
2) 12 PHM 084 – Mark D. Morgensen, R.Ph.
3) 13 PHM 004 – Jay M. Bubrick, R.Ph.
4) 13 PHM 006 – Kuldeep Grewal, R.Ph.
Pharmacy Examining Board
Agenda 1E. Prescription Drug Monitoring Program Update – Discussion and Consideration (15-70)
1) Deployment Discussion
a) Deployed on June 1, 2013
b) Alert Functionality Improvements
c) Delegate Account Functionality Improvements
d) NABP PMP Interconnect Update
2) Training and Outreach
a) Events
b) Brochures
c) Statistics Sheets
3) Policy Discussion
a) Phar 18 Rule-Writing Projects
b) Reporting of Compounded/Distributed Drugs
c) Session Time-Out Length
4) Grant Opportunity
a) 2013 SAMHSA Grant
5) Miscellaneous Items for Consideration
a) WNA Letter of Support
b) MEB Newsletter
F. Legislation/Administrative Rule Matters – Discussion and Consideration
1) LRB 2399 (71-74)
2) Amending Phar 15 Relating to Sterile Pharmaceuticals(75-76)
3) Update on Pending Rule Projects(77-78)
G. Variance Related Items – Discussion and Consideration
1) Continued Reporting Requirements
2) Variance Reports(79-80)
a) Delivery
1. Dean Clinic – Fish Hatchery (81-82)
2. Embrace Pharmacy (83-84)
3. Meriter Outpatient Pharmacy (85-88)
4. Wheaton Franciscan Pharmacy (89-90)
5. Genoa Healthcare - Madison (91-92)
b) Technician-to-Pharmacist Ratio
1. Pinnacle Pharmacy (93-96)
c) Robotic Dispensing
d) Tech-Check-Tech
1. Gundersen Lutheran (97-98)
3) Variance Requests
a) Universal Compounders LLC.(99-122)
b) Sun Prairie Hometown Pharmacy (123-128)
Pharmacy Examining Board
Agenda 2H. Board Informational Items – Discussion and Consideration
1) Current Pharmacy Inspection Form(129-132)
2) 2013 Goals List(133-136)
3) Pharmacy Board Position Statements(137-140)
4) CMS Signature Policy Revision – Discussion and Consideration (141-142)
I. Compounding Matters – Discussion and Consideration (143-144)
1) Senate Summary (145-146)
2) Legislation to Regulate Compounding Pharmacies(147-148)